327 related articles for article (PubMed ID: 17519950)
1. Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.
Yeung SY; Pucovský V; Moffatt JD; Saldanha L; Schwake M; Ohya S; Greenwood IA
Br J Pharmacol; 2007 Jul; 151(6):758-70. PubMed ID: 17519950
[TBL] [Abstract][Full Text] [Related]
2. Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.
Yeung S; Schwake M; Pucovský V; Greenwood Ia
Br J Pharmacol; 2008 Sep; 155(1):62-72. PubMed ID: 18536747
[TBL] [Abstract][Full Text] [Related]
3. Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles.
Jepps TA; Greenwood IA; Moffatt JD; Sanders KM; Ohya S
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G107-15. PubMed ID: 19389803
[TBL] [Abstract][Full Text] [Related]
4. Molecular variants of KCNQ channels expressed in murine portal vein myocytes: a role in delayed rectifier current.
Ohya S; Sergeant GP; Greenwood IA; Horowitz B
Circ Res; 2003 May; 92(9):1016-23. PubMed ID: 12690036
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells.
Yeung SY; Greenwood IA
Br J Pharmacol; 2005 Oct; 146(4):585-95. PubMed ID: 16056238
[TBL] [Abstract][Full Text] [Related]
6. Role of KCNQ channels in skeletal muscle arteries and periadventitial vascular dysfunction.
Zavaritskaya O; Zhuravleva N; Schleifenbaum J; Gloe T; Devermann L; Kluge R; Mladenov M; Frey M; Gagov H; Fésüs G; Gollasch M; Schubert R
Hypertension; 2013 Jan; 61(1):151-9. PubMed ID: 23184384
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological dissection of K(v)7.1 channels in systemic and pulmonary arteries.
Chadha PS; Zunke F; Davis AJ; Jepps TA; Linders JT; Schwake M; Towart R; Greenwood IA
Br J Pharmacol; 2012 Jun; 166(4):1377-87. PubMed ID: 22251082
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in Kv7 channel function in the cerebral and coronary circulation.
Lee S; Yang Y; Tanner MA; Li M; Hill MA
Microcirculation; 2015 Feb; 22(2):109-121. PubMed ID: 25476662
[TBL] [Abstract][Full Text] [Related]
9. Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli.
Adduci A; Martire M; Taglialatela M; Arena V; Rizzo G; Coco C; Currò D
Eur J Pharmacol; 2013 Dec; 721(1-3):12-20. PubMed ID: 24120659
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary vasoconstrictor action of KCNQ potassium channel blockers.
Joshi S; Balan P; Gurney AM
Respir Res; 2006 Feb; 7(1):31. PubMed ID: 16504007
[TBL] [Abstract][Full Text] [Related]
11. Drosophila KCNQ channel displays evolutionarily conserved electrophysiology and pharmacology with mammalian KCNQ channels.
Cavaliere S; Hodge JJ
PLoS One; 2011; 6(9):e23898. PubMed ID: 21915266
[TBL] [Abstract][Full Text] [Related]
12. Functional assembly of Kv7.1/Kv7.5 channels with emerging properties on vascular muscle physiology.
Oliveras A; Roura-Ferrer M; Solé L; de la Cruz A; Prieto A; Etxebarria A; Manils J; Morales-Cano D; Condom E; Soler C; Cogolludo A; Valenzuela C; Villarroel A; Comes N; Felipe A
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1522-30. PubMed ID: 24855057
[TBL] [Abstract][Full Text] [Related]
13. Effects of KCNQ channel modulators on the M-type potassium current in primate retinal pigment epithelium.
Pattnaik BR; Hughes BA
Am J Physiol Cell Physiol; 2012 Mar; 302(5):C821-33. PubMed ID: 22135213
[TBL] [Abstract][Full Text] [Related]
14. Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.
Mackie AR; Brueggemann LI; Henderson KK; Shiels AJ; Cribbs LL; Scrogin KE; Byron KL
J Pharmacol Exp Ther; 2008 May; 325(2):475-83. PubMed ID: 18272810
[TBL] [Abstract][Full Text] [Related]
15. Activation of KV7 channels stimulates vasodilatation of human placental chorionic plate arteries.
Mills TA; Greenwood SL; Devlin G; Shweikh Y; Robinson M; Cowley E; Hayward CE; Cottrell EC; Tropea T; Brereton MF; Dalby-Brown W; Wareing M
Placenta; 2015 Jun; 36(6):638-44. PubMed ID: 25862611
[TBL] [Abstract][Full Text] [Related]
16. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
Brueggemann LI; Haick JM; Neuburg S; Tate S; Randhawa D; Cribbs LL; Byron KL
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L476-86. PubMed ID: 24441871
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder.
Rode F; Svalø J; Sheykhzade M; Rønn LC
Eur J Pharmacol; 2010 Jul; 638(1-3):121-7. PubMed ID: 20385123
[TBL] [Abstract][Full Text] [Related]
18. KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle.
Joshi S; Sedivy V; Hodyc D; Herget J; Gurney AM
J Pharmacol Exp Ther; 2009 Apr; 329(1):368-76. PubMed ID: 19151245
[TBL] [Abstract][Full Text] [Related]
19. XE991 and Linopirdine Are State-Dependent Inhibitors for Kv7/KCNQ Channels that Favor Activated Single Subunits.
Greene DL; Kang S; Hoshi N
J Pharmacol Exp Ther; 2017 Jul; 362(1):177-185. PubMed ID: 28483800
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of KCNQ channels in larval zebrafish.
Chege SW; Hortopan GA; T Dinday M; Baraban SC
Dev Neurobiol; 2012 Feb; 72(2):186-98. PubMed ID: 21692188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
